Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor

Vande Casteele, N., Abreu, M. T., Flier, S., Papamichael, K., Rieder, F., Silverberg, M. S., … Cheifetz, A. S. (2022, February 1). Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor. Clinical Gastroenterology and Hepatology. W.B. Saunders. https://doi.org/10.1016/j.cgh.2021.01.006